Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2785386rdf:typepubmed:Citationlld:pubmed
pubmed-article:2785386lifeskim:mentionsumls-concept:C0441635lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0288472lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0018353lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0085732lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0249197lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C1420626lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C0026377lld:lifeskim
pubmed-article:2785386lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2785386pubmed:issue1lld:pubmed
pubmed-article:2785386pubmed:dateCreated1989-5-26lld:pubmed
pubmed-article:2785386pubmed:abstractTextConformational, GTP binding, and GTP hydrolytic studies are carried out with synthetically prepared N-terminal 34 residue segments (residues 2-35) of p21 ras oncogenic (12-Val) and non-oncogenic (12-Gly) proteins. It was found that these N-terminal regions bind nucleotides through their phosphate groups, and that substitution of valine for glycine produces a more pronounced alpha-helical structure and decreases the conformational flexibility. The glycine containing peptide, when compared to the valine containing analog, catalyses the hydrolysis of GTP 6 times more efficiently. Results suggest that restriction of conformational adaptation may contribute to the transforming capacity of the Val-12 p21 protein.lld:pubmed
pubmed-article:2785386pubmed:languageenglld:pubmed
pubmed-article:2785386pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:citationSubsetIMlld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2785386pubmed:statusMEDLINElld:pubmed
pubmed-article:2785386pubmed:monthAprlld:pubmed
pubmed-article:2785386pubmed:issn0006-291Xlld:pubmed
pubmed-article:2785386pubmed:authorpubmed-author:RollerP PPPlld:pubmed
pubmed-article:2785386pubmed:authorpubmed-author:NiuC HCHlld:pubmed
pubmed-article:2785386pubmed:authorpubmed-author:RAOS SSSlld:pubmed
pubmed-article:2785386pubmed:issnTypePrintlld:pubmed
pubmed-article:2785386pubmed:day14lld:pubmed
pubmed-article:2785386pubmed:volume160lld:pubmed
pubmed-article:2785386pubmed:ownerNLMlld:pubmed
pubmed-article:2785386pubmed:authorsCompleteYlld:pubmed
pubmed-article:2785386pubmed:pagination282-8lld:pubmed
pubmed-article:2785386pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:meshHeadingpubmed-meshheading:2785386-...lld:pubmed
pubmed-article:2785386pubmed:year1989lld:pubmed
pubmed-article:2785386pubmed:articleTitleComparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments.lld:pubmed
pubmed-article:2785386pubmed:affiliationDivision of Metabolism and Endocrine Drug Products, FDA, Rockville, MD 20852.lld:pubmed
pubmed-article:2785386pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2785386pubmed:publicationTypeComparative Studylld:pubmed